LivaNova to Present Autonomic Regulation Therapy Findings for Heart Failure During European Society of Cardiology Congress 2020
LivaNova, a market-leading medical technology and innovation company, will present an ePoster at the European Society of Cardiology (ESC) Congress 2020 on the potential for autonomic regulation therapy (ART) via vagus nerve stimulation to improve long-term cardiovascular function in patients with heart failure.
The LivaNova VITARIA® System delivers ART via mild electrical impulses applied to the right vagus nerve to increase parasympathetic activity in ways that improve regulation of cardiovascular function, including electrophysiological stability, in patients with advanced heart failure.
The following ePoster will be available starting today: “Multi-Year Improvement in Autonomic Tone, Baroreceptor Sensitivity and Cardiac Electrical Stability Using Vagus Nerve Stimulation in Patients with HFrEF in the ANTHEM-HF Study”. Bruce D. Nearing, PhD, Inder S. Anand, MD, Imad Libbus, PhD, Lorenzo A. DiCarlo, MD, Bruce H. KenKnight, PhD and Richard L. Verrier, PhD, FACC
If interested in learning more about how the LivaNova VITARIA® System treats chronic heart failure, I’d be happy to connect you with an expert to discuss further.
On behalf of LivaNova